https://www.selleckchem.com/pr....oducts/Gefitinib.htm
9% and 99.2%, respectively, of women at high risk. There were significant differences among groups for both outcomes ( 0.001). There was also a significant difference among groups ( 0.001) in terms of previous falls and fragility fractures. Lastly, there were significant differences ( 0.05) among groups in using antihypertensive drugs, antiplatelet agents, anticoagulants, antidepressants, anti-osteoporotic drugs, and vitamin D, and/or calcium supplementation. Physical performance, prevalence of falls and fragility fracture
Like
Comment
Share
